Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol versus placebo for depressive symptoms in major depressive disorder
IRCT201508277373N6Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in major depressive disorder (MDD) (2 arms), sponsored by Arak University of Medical Sciences. Started Jul 2015; status: completed.
02
Drugs
allopurinol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201508277373N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201508277373N6.